Boosting Bispecific Antibody Yields with >98% Purity

Ebook

Bispecific antibodies (bsAbs) are shaping the future of therapeutics, but challenges like limited throughput, low yields, and chain mispairing across diverse formats can slow progress.

This white paper shares practical strategies and real-world case studies to help you tackle these hurdles. Discover how optimized production methods can deliver better results, even for the most complex bsAb formats.

Download the white paper to explore:

• Innovative platforms for rapid identification of optimal bsAb pairings
• Customized purification workflows that consistently deliver >98% heterodimer purity
• How adjusting HC/LC ratios can boost yield and purity